Inhaled GM-CSF in neonatal mice provides durable protection against bacterial pneumonia
Open Access
- 2 August 2019
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (8) , eaax3387
Abstract
Pneumonia poses profound health threats to preterm infants. Alveolar macrophages (AMs) eliminate inhaled pathogens while maintaining surfactant homeostasis. As AM development only occurs perinatally, therapies that accelerate AM maturation in preterms may improve outcomes. We tested therapeutic rescue of AM development in mice lacking the actin-bundling protein L-plastin (LPL), which exhibit impaired AM development and increased susceptibility to pneumococcal lung infection. Airway administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) to LPL−/− neonates augmented AM production. Airway administration distinguishes the delivery route from prior human infant trials. Adult LPL−/− animals that received neonatal GM-CSF were protected from experimental pneumococcal challenge. No detrimental effects on surfactant metabolism or alveolarization were observed. Airway recombinant GM-CSF administration thus shows therapeutic promise to accelerate neonatal pulmonary immunity, protecting against bacterial pneumonia.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI104732)
- National Institute of Allergy and Infectious Diseases (R21AI142723)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR048335)
This publication has 45 references indexed in Scilit:
- The Cytokine TGF-β Promotes the Development and Homeostasis of Alveolar MacrophagesImmunity, 2017
- Three Unique Interstitial Macrophages in the Murine Lung at Steady StateAmerican Journal of Respiratory Cell and Molecular Biology, 2017
- Flow Cytometry Reveals Similarities Between Lung Macrophages in Humans and MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2016
- Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating MonocytesImmunity, 2013
- A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 yearsArchives of Disease in Childhood - Fetal and Neonatal Edition, 2012
- A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem CellsScience, 2012
- NF-κB Signaling in Fetal Lung Macrophages Disrupts Airway MorphogenesisThe Journal of Immunology, 2011
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Granulocyte-Macrophage Colony-Stimulating Factor in Amniotic Fluid and in Airway Specimens of Newborn InfantsPediatric Research, 1997
- Alveolar Macrophages in Perinatal InfantsPediatrics, 1984